The Supreme Court appeared unconvinced Monday that the FDA acted unfairly in denying sweet-flavored vaping products after a ...
In the ongoing case, vaping companies argue that the FDA was “arbitrary and capricious” in rejecting applications for ...
The focal point of the case is 2009 law enacted by Congress that gives the Food and Drug Administration a mandate to curb the ...
The End-of-Phase 2 meeting resulted in alignment with the FDA on the proposed Phase 3 study design, including the inclusion/exclusion criteria, primary and secondary efficacy objectives, definition of ...